The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

Neurofibrillary tangles (NFTs) are a hallmark of Alzheimer’s disease, formed by the accumulation of tau protein into ...

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

The American Cancer Society Cancer Action Network (ACS CAN) gathered at the state capitol to advocate for LB253, a bill proposed by Senator Elio ...

SiPhox Health expects to field a service that’ll let people conduct blood tests in their homes and see results in about an ...

Researchers say CSF biomarker test correlates with the severity of cognitive decline, independent of other factors, including brain amyloid deposition.

Cancer survivors want to see more access to screenings that they call "a game changer." It's called biomarker testing, which analyzes a patient's tissue, blood or other bodily fluids to help pinpoint ...

From foundational technologies to cutting-edge microfluidics, scientists use the latest wastewater surveillance techniques to ...

A blood-based biomarker test may be a reliable method for predicting or ruling out Alzheimer’s disease-related pathology and ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test can detect small amounts of the clumping-prone tau protein and its misfolded pathological forms ...

A cerebrospinal fluid biomarker test can detect early Alzheimer's pathology by identifying small amounts of clumping-prone tau protein and its misfolded forms, years before they appear on brain scans.